Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study.
Jingcheng ZhaoTorsten DahlénGustaf EdgrenPublished in: Vox sanguinis (2020)
Transfusion count and costs for patients with MDS increased markedly with IPSS-R risk category, but were similar across age groups. Transfusion costs were considerable for the highest IPSS-R risk categories.
Keyphrases